Although the role of DNAJB9 in regulating autophagy to influence chemotherapy resistance is unknown, the SNHG5/miR-32/DNAJB9 axis could be an efficient target for developing modalities to increase chemosensitivity in AML patients. The gene discussed is SNHG5; the disease is acute myeloid leukemia.